Table 3.

Outcomes

OutcomeLevofloxacin Group (n=20)Placebo Group(n=19)P Value
Reduction in BK viral load at 3 mo (%)70.3±42.569.1±39.50.93
Patients with >50% reduction in BK viral load at 3 mo15 (75)13 (68)0.73
Reduction in BK viral load at 6 mo (%)82.1±34.790.5±22.20.38
Patients with >50% reduction in BK viral load at 6 mo16 (84) (n=19)17 (89) (n=19)>0.99
Increase in BK viral load at 3 mo 5 (25)3 (16)0.69
Sustained BK viremia at 3 mo 13 (65)14 (74)0.73
Sustained BK viremia at 6 mo11 (58)13 (68)0.74
Allograft loss0 (0)2 (11)0.49
  • Unless otherwise noted, values are the number (percentage) of patients. Values expressed with a plus/minus sign are the mean±SD.